Evidence map›Paper›PMID 33752749›Full record

ArticleActa neuropathologica communications2021

Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson's disease.

I Friedrich, K Reimann, S Jankuhn, E Kirilina, J Stieler, M Sonntag, J Meijer, N Weiskopf, T Reinert, T Arendt and 1 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

I FriedrichPaul Flechsig Institute of Brain Research, Medical Faculty, Universität Leipzig, Leipzig, Germany.
K ReimannPaul Flechsig Institute of Brain Research, Medical Faculty, Universität Leipzig, Leipzig, Germany.
S JankuhnFelix Bloch Institute for Solid State Physics, Faculty of Physics and Earth Sciences, Universität Leipzig, Leipzig, Germany.
E KirilinaDepartment of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
J StielerPaul Flechsig Institute of Brain Research, Medical Faculty, Universität Leipzig, Leipzig, Germany.
M SonntagPaul Flechsig Institute of Brain Research, Medical Faculty, Universität Leipzig, Leipzig, Germany.
J MeijerFelix Bloch Institute for Solid State Physics, Faculty of Physics and Earth Sciences, Universität Leipzig, Leipzig, Germany.
N WeiskopfDepartment of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
T ReinertDepartment of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
T Arendt *Paul Flechsig Institute of Brain Research, Medical Faculty, Universität Leipzig, Leipzig, Germany.
M Morawski *Paul Flechsig Institute of Brain Research, Medical Faculty, Universität Leipzig, Leipzig, Germany. markus.morawski@medizin.uni-leipzig.de.ORCID 0000-0002-3817-5186
Leipzig University · DEMax Planck Institute for Human Cognitive and Brain Sciences · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron is essential for neurons and glial cells, playing key roles in neurotransmitter synthesis, energy production and myelination. In contrast, high concentrations of free iron can be detrimental and contribute to neurodegeneration, through promotion of oxidative stress. Particularly in Parkinson's disease (PD) changes in iron concentrations in the substantia nigra (SN) was suggested to play a key role in degeneration of dopaminergic neurons in nigrosome 1. However, the cellular iron pathways and the mechanisms of the pathogenic role of iron in PD are not well understood, mainly due to the lack of quantitative analytical techniques for iron quantification with subcellular resolution. Here, we quantified cellular iron concentrations and subcellular iron distributions in dopaminergic neurons and different types of glial cells in the SN both in brains of PD patients and in non-neurodegenerative control brains (Co). To this end, we combined spatially resolved quantitative element mapping using micro particle induced X-ray emission (µPIXE) with nickel-enhanced immunocytochemical detection of cell type-specific antigens allowing to allocate element-related signals to specific cell types. Distinct patterns of iron accumulation were observed across different cell populations. In the control (Co) SNc, oligodendroglial and astroglial cells hold the highest cellular iron concentration whereas in PD, the iron concentration was increased in most cell types in the substantia nigra except for astroglial cells and ferritin-positive oligodendroglial cells. While iron levels in astroglial cells remain unchanged, ferritin in oligodendroglial cells seems to be depleted by almost half in PD. The highest cellular iron levels in neurons were located in the cytoplasm, which might increase the source of non-chelated Fe

Indexed as

AgedAged, 80 and overAutopsyBrain MappingEvaluation Studies as TopicFemaleHumansImmunohistochemistryIronMaleMiddle AgedParkinson DiseaseRadiographySubstantia NigraX-RaysIron

Identifiers

PMID33752749
PMCPMC7986300
OpenAlexW3137732484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.